Policy & Medicine

This Week on Policy and Medicine Podcast November 23, 2024: Legal Battles, Regulatory…

Thomas Sullivan Nov 23, 2024 0

This week on the Policy and Medicine Podcast, November 23, 2024 we take a comprehensive look at some of the most pressing issues in healthcare policy and regulation. The episode kicks off with an in-depth analysis of a major $300 million settlement agreed upon by drug distributors with insurance companies to resolve claims from the opioid crisis…

Policy and Medicine Compliance Update – November 2023…

Thomas Sullivan Dec 1, 2023 0

Policy and Medicine Compliance Update October 2023 Issue…

Thomas Sullivan Oct 20, 2023 0

This Week on Policy and Medicine Podcast November 23, 2024:…

This week on the Policy and Medicine Podcast, November 23, 2024 we take a comprehensive look at some of the most pressing issues in healthcare policy and regulation. The episode kicks off with an…

CMS Finalizes TEAM through IPPS Final Rule

On August 28, as part of its Fiscal Year 2025 Hospital Inpatient Prospective Payment System (IPPS) Final Rule, the Centers for Medicare & Medicaid Services (CMS) finalized the Transforming Episode…

HHS Issues Proposed Rule to Update Health IT Regulations

The United States Department of Health and Human Services (HHS) recently proposed a rule that would require HHS contractors to use health information technology (IT) that is certified or accepted by…

Maryland PDAB Releases Draft Action Plan for Establishing UPLs

Maryland’s Prescription Drug Affordability Board (PDAB) released its draft action plan for establishing upper payment limits (UPLs) for drugs identified as causing (or likely to cause) affordability…

Drug Distributors Agree to Pay $300 Million to Health Plans

The nation’s three largest drug distributors – McKesson Corp, Cardinal Health Inc, and Cencora Inc – recently agreed to pay $300 million to health plans to settle lawsuits over their role in the…

FTC Sues PBMs and GPOs For Anti-Competitive Rebate Practice

The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest prescription drug benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI),…

Unlocking the Fatty Liver Mistry: The Silent Threat of Fatty…

In the inaugural episode of "Unlocking the Fatty Liver Mistry," Dr. Neeraj Mistry, Chief Medical Officer of the Fatty Liver Foundation, shares crucial insights on the often-overlooked health…

Oncology Unscripted with John Marshall, MD: Are You Overdosing…

In the latest episode of Oncology Unscripted, Dr. John Marshall addresses critical issues concerning the dosing practices in oncology, particularly questioning the prevailing approach of using maximum…

Updates from FDA’s Office of Prescription Drug Promotion:…

In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the Director of the Office of Prescription Drug Promotion (OPDP) at the…

Walgreens Reaches $106.8 Million False Claims Act Settlement…

Walgreens Boots Alliance Inc. and Walgreen Co. (collectively, “Walgreens”) agreed to pay $106.8 million in two settlements (here and here) to resolve allegations that Walgreens violated the False…

Reevaluating the RUC Committee: Addressing Specialty…

With the new administration and congress coming, one simple reform to increase the number of primary care physicians and reduce healthcare costs is updating the Relative Value Units (RVU) system. The…

Acadia Healthcare Reaches $19.85 Million Settlement to Resolve…

Acadia Healthcare Company, Inc., has reached a settlement agreement with the United States Department of Justice (DOJ) to resolve allegations that it violated the False Claims Act and certain state…